CACI holder plans Rule 144 sale of 2,000 shares

A stockholder of CACI International has filed a Rule 144 notice to sell 2,000 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of 1,230,125.

Rhea-AI Filing Summary

A stockholder of CACI International has filed a Rule 144 notice to sell 2,000 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of 1,230,125. The filing lists 22,085,774 shares of common stock outstanding.

The shares to be sold were acquired mainly through RSU and PSU vesting from CACI International on 10/01/2024 in several separate vesting transactions with different share amounts. The seller represents that they are not aware of any undisclosed material adverse information about CACI’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CACI (CACI) Form 144 filing disclose?

The Form 144 filing discloses a planned sale of 2,000 CACI International common shares on the NYSE, with an aggregate market value of about 1,230,125. It is a notice of intent to sell restricted or control securities under Rule 144.

How many CACI (CACI) shares are planned to be sold and where?

The filing shows an intention to sell 2,000 shares of CACI International common stock through UBS Financial Services Inc. on the NYSE. The approximate sale date listed is 02/10/2026, with an aggregate market value of 1,230,125.

How were the CACI (CACI) shares in the Form 144 acquired?

The shares were acquired via RSU and PSU vesting from CACI International on 10/01/2024. Several separate vesting transactions are listed, each with different share amounts and a stated payment date of 02/10/2026, and the nature of payment marked as N/A.

What does the Form 144 say about CACI (CACI) shares outstanding?

The notice reports 22,085,774 CACI International common shares outstanding. This figure provides context for the relative size of the planned 2,000-share sale but is not itself part of the transaction being registered for resale under Rule 144.

When might the CACI (CACI) shares be sold under this Form 144?

The filing lists an approximate date of sale of 02/10/2026 for the 2,000 CACI International common shares. This date is indicative rather than guaranteed, as actual sales can depend on market conditions and the seller’s instructions to their broker.

What representation does the seller make in the CACI (CACI) Form 144?

The person on whose account the CACI shares are to be sold represents that they do not know any material adverse information about CACI’s current or prospective operations that has not been publicly disclosed, in line with the standard Rule 144 notice language.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/10/2026 - 02:24 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001604478
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CACI International Inc.
SEC File Number	001-31400
Address of Issuer	12021 Sunset Hills Road Reston VIRGINIA 20190
Phone	703-841-7800
Name of Person for Whose Account the Securities are To Be Sold	Joseph Koegel Jr.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	2000	1230125	22085774	02/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/01/2024	RSU Vesting	CACI International			274	02/10/2026	N/A
Common Stock	10/01/2024	RSU Vesting	CACI International			292	02/10/2026	N/A
Common Stock	10/01/2024	RSU Vesting	CACI International			329	02/10/2026	N/A
Common Stock	10/01/2024	PSU Vesting	CACI International			895	02/10/2026	N/A
Common Stock	10/01/2024	PSU Vesting	CACI International			210	02/10/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Joseph Koegel Jr.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)